Lyell Immunopharma, Inc. (LYEL)
NASDAQ·Healthcare·Biotechnology
$21.49
-5.00%
Mkt Cap $522.79M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$45.00
Range $45.00 – $45.00
Implied Upside
+109.4%
Consensus $45.00 vs current $21.49
NASDAQ·Healthcare·Biotechnology
$21.49
-5.00%
Mkt Cap $522.79M
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$45.00
Range $45.00 – $45.00
+109.4%
Consensus $45.00 vs current $21.49